In this presentation, Dr. Kamyar Hadian (head of the and Screening Platform’ at the HelmholtzZentrum München in Munich/Germany) talk about use in – and microtissue-based assays.

has highly emerged in the past years. Especially High-Content Screening (HCS) has gained strong acceptance in the field of target validation and compounds screening as a method to follow more innovative and sophisticated assays …


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

0 Comments

Leave a Reply